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Makaverich et al. [Environ Healb Perspect 103:574-581 (1995)] reported that the uterotrophic
activity ofthe phytoestrogen coumestrol in the immature ovariectomized ratwas atypical in that
itwas notassociated with increased utenrne hyperplasia and DNA content. Wepreviously report-
ed that counestrol gave atypical esudiol-ype uterotrophic response in the immature intact rat,
yielding increases i'm uterine epieidlial cell height, glandular formation, celi labeling, and DNA
content. These papers did not answer the question ofwhether there is a basic difference between
theovariectomized andthe intact rat uterotrophic assays. In this paper,we reportthat coumestrol
gives a typical estradiol-type uterotrophic response in uterotrophic assays using immature intact,
immature ovariectomized, and mature ovariectomiized rats. We conduded that the uterotrophic
activity ofcoumestrol is typical ofthenatura estrogen estradiol. Keywork endocrine dismption,
immature rat, ovariectomed rats, phytoestrogens, ual development. Environ Health Perspect
108:631-634 (2000). [Online31 May2000]
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Makaverich et al. (1) reported that the phy-
toestrogen coumestrol gives an atypical posi-
tive response in the ovariectomized immature
rat uterotrophic assay. Although an increase
in uterine weight was observed, they reported
no accompanying increase in uterine cell
division or DNA content. This led the
authors to suggest that the positive utero-
trophic response for coumestrol was mecha-
nistically distinct from that of estradiol,
which is known to be accompanied by con-
comitant increases in uterine cell division
and DNA content. Subsequently, we report-
ed (2) that the uterotrophic activity of
coumestrol in the immature intact rat was
indistinguishable from that ofestradiol ben-
zoate (E2B); both induced uterotrophic
responses that were accompanied by increases
in uterine epithelial cell height, gland forma-
tion, cell division, and DNA content. We did
not repeat the original immature ovariec-
tomized rat uterotrophic assay reported by
Makaveric (1) due to the scarcity and expense
ofcoumestrol; thus, it was not clear ifthis dif-
ference in assay outcome between Makaverich
et al. (1) and our study (2) was absolute, or a
reflection of an intrinsic difference between
the uterotrophic assay in the immature rat
versus the ovariectomized rat. In this paper,
we describe the results ofuterotrophic assays
of E2B and coumestrol using immature
intact, immature ovariectomized, and
mature ovariectomized rats. We used the
same dose levels (milligrams per kilogram) of
the two test agents for each ofthe test proto-
cols in order to compare the relative sensitiv-
ities ofthe protocols. We used the same dose
level of coumestrol as in our earlier study,
the same dose estimated by Makaverich et al.
(1) to have been used in theiroriginal studies
(60 mg/kg/day).
Materials and Methods
Chemicals. Coumestrol, estradiol benzoate
(E2B), and arachis oil were as previously
described (2). We obtained 5-bromo-
deoxyuridine (BrdU), 3,3'-diaminobenzidine,
and orcinol from Sigma Chemical Company
(Poole, Dorset, UK). All antibodies were sup-
plied by DAKO Ltd (High Wycombe, UK).
Animals. Three groups of female
Alpk:AP rats were obtained from the breed-
ing unit at AstraZeneca (Alderley Park,
Macclesfield, Cheshire, UK). As in our pre-
vious uterotrophic assays (3), the first group
offemale rats (intact weanlings) was 21-22
days ofage and had body weights of38-48
g. The second group offemale rats [ovariec-
tomized (OVX) weanlings] was ovariec-
tomized at 21-22 days of age and dosed
between 29 and 30 days ofage, as described
by Makaverich et al. (1). The final group of
animals (OVX matures) consisted offemale
rats that were ovariectomized at 6-8 weeks
of age and dosed at 7-9 weeks of age, as
previously described (3). All animals were
housed and maintained as previously
described (2). Diet and water were available
ad libitum. Intact weanlings were acclima-
tized for 24 hr before being dosed, and all
OVX females were acclimatized for 4 days
before dosing. All animals were dosed over
the same 3-day period. The dose levels of
coumestrol used by Makaverich et al. (1)
varied between experiments and were not
always clearly stated. However, the authors
noted that uterine weight was doubled
when rats were exposed to 100 pg coume-
strol/mL drinking water; they estimated that
this exposure yielded 60 mg coumestrol/kg
bodyweight/day (1). Therefore, we used the
dose of 60 mg/kg/day coumestrol for the
present experiments.
Uterotrophic assays. The uterotrophic
activities ofcoumestrol (60 mg/kg) and E2B
(80 pg/kg) were investigated as described pre-
viously (2). The test agents were dissolved
(E2B) or homogeneously suspended (coume-
strol) in arachis oil and administered by a sin-
gle oral gavage on each of three successive
days using a dosing volume of5 mL/kg body
weight. Twenty-four hours after the final
dose, animals were killed by an overdose of
Fluothane (AstraZeneca Pharmaceuticals) fol-
lowed by cervical dislocation. At the time of
death, we recorded vaginal opening (weanling
intact and immature OVX females) or took
vaginal smears (mature OVX females). Test
groups, daily dose levels, and animal group
sizes are shown in Table 1. We administered
BrdU in the drinking water (0.8 mg/mL) for
the duration ofthe experiment beginning 24
hr before the gavage treatments, as described
previously (2).
The reproductive tract was excised and
handled as previously described (2) to yield
the individual weights of the blotted uterus,
the vagina, and the cervix. The uterus was
then cut so the left horn of the uterus,
together with the junction to the cervix,
could be processed for histopathology (2).
The right horn was flash frozen in liquid
nitrogen and stored at -70°C for possible
fiture use.
Determination ofuterine hyperplasia.
The left uterine horn, together with its junc-
tion to the cervix, from each animal was
fixed in 10% formal saline and processed to
paraffin wax. Longitudinal sections were
stained to reveal BrdU as described previous-
ly (2,4). We determined the labeling index
for epithelial cells of the uterine lumen as
well as for the endometrial glands and stro-
ma (500 cells/animal were assessed where
possible) (2).
Determination ofuterine hypertrophy.
Uterine sections were stained with hema-
toxylin and eosin. We calculated the mean
endometrial and epithelial cell height
on the basis of 10 locations measured per
animal (2).
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Statisticalassessmentofdata. We assessed
statistical difference ofall uterotrophic (Table
1) andhypertrophy data (Table 2)byanalysis
of variance (ANOVA) (5). We analyzed the
hyperplasia data (Table 3) using ANOVA
after a double arcsine transformation (6).
Comparisons were carried out separately for
all observations between the control group
and all test groups.
Results
Uterotrophic assays. The results of the
uterotrophic assays performed using the
three test protocols are shown in Table 1.
The data generated for coumestrol and E2B
in the intact weanlings confirmed previously
published observations (2). Bothcompounds
induced comparable andsignificant increases
in blotted uterine weight, vaginal weight,
and cervicalweight (Figure 1).
The OVXweanling females also hadsig-
nificantly increased uterine, vaginal, and
cervical weights after exposure to both com-
pounds. Coumestrol and E2B induced simi-
lar responses and the magnitude of these
responses was comparable to those observed
in the intactweanling females (Figure 1).
Coumestrol induced significant increases
in tissueweights in the OVX mature females.
However, the magnitude of these responses
was lower than those observed in the two
weanling groups. Specifically, the average
fold increase in uterine and cervical weights
for the weanling intact and weanling OVX
females was -3- to 4-fold, whereas those for
the mature OVX females was only -1.6-fold.
Only the fold increase in vaginal weight was
similar across the three groups of females
(-1.8-fold; Figure 1). E2B did not signifi-
cantly increase the uterine or cervical
weights in the mature OVX uterotrophic
assay, but we observed a small increase in
the vaginal weight (Table 1, Figure 1). This
is consistent with earlier observations (3)
and was due to the use of a lower E2B dose
than is optimum for this chemical in oral
uterotrophic assays (enforced by our deci-
sion to use standardized dose levels across
the three testprotocols).
Measurement ofbypertrophy. Treatment
with coumestrol led to a highly significant
increase in the height ofthe uterine epithe-
lium in all three groups offemales (Table 2;
Figure 2A). The effect was most prominent
in 21-22-day-old intact weanlings and least
prominent in mature OVX animals, as
observed with the tissue weight data. A
highly significant increase in the height of
the endometrium was observed in imma-
ture OVX and intact immature animals
(OVX > intact) (Figure 2B). However,
there was no effect in the mature OVX
females, which is consistent with the lack of
tissue weightgain.
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Table 2. Effect of coumestrol (60 mg/kg), E2B (80 pg/kg), and arachis oil (5 mL/kg) on the height (mean +
SD) ofthe uterine epithelium and endometrium.
No. of Epithelium height Endometrium height
Group Compound females (pm) (pm)
Immature intact Arachis oil 6 11.0 ± 1.4 193.6 ± 39.6
Coumestrol 6 41.0 ± 7.6** 305.8 ± 40.5**
E2B 6 34.7+6.2** 235.1 +39.8
Immature OVX Arachis oil 7 9.5 ± 1.2(6) 123.2 ± 24.1 (6)
Coumestrol 8 26.5 ± 5.0** 299.5 ± 49.8**
E2B 4 14.7 ± 2.8** (3) 245.4 ± 43.9**
Mature OVX Arachis oil 8 9.6 ± 1.2 275.1 ± 97.9
Coumestrol 8 20.1 ± 5.0** (7) 365.7 ± 85.1* (7)
E2B 8 13.6±3.6* 282.7±51.0
Numbers in parentheses indicate the number of observations upon which the group mean is based. Data were assessed
for statistical significance byANOVA.
*p< 0.05; **p< 0.01.
Table 3. Effect of coumestrol (60 mg/kg), E2B (80 pg/kg), and arachis oil (5 mL/kg) on the labeling index of
the uterine epithelium and endothelium.
Labeling Index (%) ± SD
No. of Endometrium
Group Compound females Epithelium Glands Stroma
Intact weanling Arachis oil 6 0.8 ± 0.6 3.9 ± 3.9 3.3 ± 2.8
Coumestrol 6 36.1 ± 7.7** 61.4± 18.5** 31.2± 28.9*
E2B 6 9.7± 12.1 52.8± 21.9** 28.0 ± 31.3
Weanling OVX Arachis oil 7 0.9 ± 0.5 (6) 0.9 ± 0.7 0.7 + 0.2
Coumestrol 8 70.6± 17.1** 91.6 ±9.6** 64.6± 17.2**
E2B 4 38.3 ± 13.7** (3) 55.6 ± 14.2** 27.7 ± 14.4**
Mature OVX Arachis oil 8 1.1 ±0.8 3.0± 1.4 0.4± 0.1
Coumestrol 8 36.1 ± 18.2** (7) 70.4 ± 9.4** 3.3 ± 0.2**
E2B 8 1.6 ±0.8 5.0 ±3.0 0.3 ±0.2
Numbers in parentheses indicate the group size upon which observations were made. Data were assessed for statistical
significance byANOVAfollowing double arcsine transformation.
*p< 0.05; **p< 0.01 as compared to controls.
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Figure 1. Activity of coumestrol (COUM; 60 mg/kg), E2B (80 pg/kg), and arachis oil (A0; 5 mtlkg) in the rat
uterothrophic assay. Data taken from Table 1 are shown as group mean ± SD and were assessed for sig-
nificance byANOVA. The numbers above columns indicate the number of animals per group.
**p> 0.01.
After treatmentwith E2B, as with coume-
strol, significant increases in the height ofthe
uterine epithelium were observed in all
treated females, with the most significant
effect in intact weanlings (Figure 2A). The
responses observed in both groups of OVX
females were similar.
Determination ofuterine hyperplasia.
Coumestrol exposure led to a significant
increase in the labeling index of the uterine
epithelium and the glands and stroma ofthe
endometrium in all three groups of females
(Table 3, Figure 3). In all three sets of
females, we observed thehighestfrequency of
S-phase cells in the glands and the lowest fre-
quency in the stroma. The effect of coume-
strol on the labeling index ofthe uterus was
most prominent in immature OVX animals
(Figure3).
After treatmentwith E2B, there was asig-
nificant increase in the labeling index of the
uterine epithelium in immature OVX ani-
mals only (Table 3). We observed increases
in the labeling indices in the glands and stro-
ma of the endometrium of the immature
OVX animals and in the glands of the
21-22-day-old weanlings. E2B induced a
marginal, though significant (p < 0.05),
increase in the total number oflabeled uter-
ine cells (Figure 3). As with coumestrol, the
frequency ofS-phase cells was highest in the
glands and lowest in the stroma in all three
groups offemales.
Discussion
The present datasupplement those described
earlier (2) and confirm that coumestrol gives
a classical estradiol-type uterotrophic
response in the three protocols used here for
the rat uterotrophic assay (Table 4). As
noted earlier (2, the claim ofMarkaverich et
al. (1) that coumestrol was an atypical
uterotrophic agent in the immature ovariec-
tomized rat was based on limited data; the
present observations seem to override those
earlier data. It is critical to know, for purpos-
es of human hazard estimation, if phytoe-
strogens such as coumestrol act differently in
the uterotrophic assay than do natural or
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Figure 2. Effect of coumestrol (COUM; 60 mg/kg), E2B (80 pg/kg), and arachis oil (AO; 5 mL/kg) on the height(in micrometers) of(A) the uterine epithelium and (8)
the endometrium. Data were assessed for statistical significance by ANOVA. The number above each bar indicates the number of females in each group from
which measurements could be made.
*p>0.05; **p< 0.01.
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Figure 3. Effect of coumestrol (COUM; 60 mg/kg), E2B (80 pg/kg), and arachis oil (AO; 5 mL/kg) on the label-
ing index ofthe uterus (epithelium and endometrium combined). Data were assessed for statistical signifi-
cance byANOVAfollowing a double arcsine transformation.
*p>0.05;**p>0.01.
Table 4. Qualitative outcome for each parameter measured after exposure to coumestrol (60 mg/kg) or
E2B (80 pg/kg).
Immature intact Immature OVX Mature OVX
End point Coumestrol E2B Coumestrol E2B Coumestrol E2B
Blotted uterine weight ** ** ** ** **
Vaginal weight ** ** ** ** **
Cervical weight ** ** ** ** **
Epithelium height ** ** ** ** ** *
Endometrium height ** ** ** *
Uterine labeling indexa ** * ** ** **
-, Not significant. Data were assessed for statistical significance by ANOVA (following double arcsine transformation in
the case ofthe labeling index).
8Combined epithelium and endometrium. *p < 0.05; **p< 0.01.
synthetic estrogens. The present data do not
support that claim.
The uterotrophic activity ofa fixed dose
level of coumestrol was similar across the
three test protocols, whereas that of a fixed
dose level of E2B was much reduced in
mature animals. This may reflect accelerated
metabolic clearance of E2B by the mature
animals (but apparently not of coumestrol)
due to their more well developed hepatic
metabolic competence.
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